ArticleAngewandte Chemie (International ed. in English)2026
Catalytic Enantioselective Multicomponent Reactions of Sulfoxonium Ylides Enabled by a Formal Rearrangement-A Versatile Entry to Enantioenriched α-Sulfanyl Carbonyl Compounds.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Sulfur ylides have emerged as versatile carbenoids for catalytic enantioselective X-H insertion reactions (X = C, N, O, and S), while offering a better safety profile compared to traditional diazo-based metal carbene precursors. However, the realization of valuable multicomponent reactions (MCRs) with sulfur ylides has been so far out of reach. Here, we report the enantioselective MCR of sulfoxonium ylides, aldehydes, and thiols catalyzed by a chiral phosphoric acid. Departing from carbenoid reactivity, the reaction pathway entails two sequential but nonoverlapping catalytic cycles, where the assembly of the components is followed by a delayed stereodetermining rearrangement across the central C─C bond of the molecule. The organocatalytic MCR delivers β-hydroxy-α-sulfanyl carbonyl products as single anti-diastereoisomers and generally in high yields and enantioselectivities. These products cannot be readily accessed by other catalytic means and are synthetic linchpins to a variety of α-sulfanyl carbonyl compounds via stereospecific substitutions of their hydroxy group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.